发明名称 CYSTIC FIBROSIS TREATMENT COMPRISING NITRIC OXIDE
摘要 One aspect of the invention provides a method of treating a subject diagnosed with cystic fibrosis, but not having a pathological bacterial colonization in either lung. The method includes administering gaseous nitric oxide at a concentration of between about 40 ppm and about 400 ppm to the subject's lungs wherein said nitric oxide is administered by inhalation, and further wherein said nitric oxide induces conformational change in the cystic fibrosis transmembrane conductance regulator (CFTR) in the cells of the lung of the subject. Another aspect of the invention provides a kit comprising: an apparatus for administering gaseous nitric oxide to a subject and instructions for administering the gaseous nitric oxide according to one or more of the methods described herein.
申请公布号 US2016271056(A1) 申请公布日期 2016.09.22
申请号 US201415035898 申请日期 2014.12.11
申请人 NITRIC SOLUTIONS INC. ;12TH MAN TECHNOLOGIES, INC. 发明人 Miller Christopher;Regev Gilly;Stenzler Alex
分类号 A61K9/00;A61M16/12;A61K33/00 主分类号 A61K9/00
代理机构 代理人
主权项 1. A method of treating a subject diagnosed with cystic fibrosis, but not having a pathological bacterial colonization in either lung, the method comprising: administering gaseous nitric oxide at a concentration of between about 40 ppm and about 400 ppm to the subject's lungs; wherein the nitric oxide is administered by inhalation; and further wherein the nitric oxide induces conformational change in the cystic fibrosis transmembrane conductance regulator (CFTR) in the cells of the lung of the subject.
地址 Alberta CA